TuHURA Biosciences (HURA)
2.19
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 8-K TuHURA Biosciences, Inc. For: May 26
May 29, 2026 5:00 PM - SEC Filing
Form 4 TuHURA Biosciences, Inc. For: May 28 Filed by: Bianco James A.
May 29, 2026 4:37 PM - SEC Filing
Form 10-Q TuHURA Biosciences, Inc. For: Mar 31
May 15, 2026 5:21 PM - SEC Filing
Form 8-K TuHURA Biosciences, Inc. For: May 15
May 15, 2026 5:11 PM - SEC Filing
TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 15, 2026 5:00 PM - PR NewsWire
TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
May 12, 2026 7:30 AM - PR NewsWire
Form 8-K/A TuHURA Biosciences, Inc. For: Apr 02
April 30, 2026 4:45 PM - SEC Filing
Form 10-K/A TuHURA Biosciences, Inc. For: Dec 31
April 30, 2026 4:32 PM - SEC Filing
Citizens Starts TuHURA Biosciences (HURA) at Market Outperform
April 27, 2026 1:58 AM - StreetInsider
Form 8-K TuHURA Biosciences, Inc. For: Apr 21
April 22, 2026 7:40 AM - SEC Filing
TuHURA secures $50 million credit facility from major shareholder
April 22, 2026 7:30 AM - StreetInsider
TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028
April 22, 2026 7:30 AM - PR NewsWire
Rodman & Renshaw Starts TuHURA Biosciences (HURA) at Buy
April 15, 2026 8:08 AM - StreetInsider
TuHURA Biosciences enters $50 million at-the-market offering agreement
April 8, 2026 4:35 PM - StreetInsider
Form 424B5 TuHURA Biosciences, Inc.
April 8, 2026 4:33 PM - SEC Filing
Form 8-K TuHURA Biosciences, Inc. For: Apr 02
April 8, 2026 4:16 PM - SEC Filing
TuHURA Biosciences names Amanda Garofalo as clinical operations SVP
April 7, 2026 12:27 PM - StreetInsider
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
April 7, 2026 12:27 PM - PR NewsWire
TuHURA Biosciences hires Amanda Garofalo as clinical operations SVP
April 7, 2026 7:47 AM - StreetInsider
Form 8-K TuHURA Biosciences, Inc. For: Apr 01
April 1, 2026 8:01 AM - SEC Filing
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
April 1, 2026 7:45 AM - PR NewsWire
Form 10-K TuHURA Biosciences, Inc. For: Dec 31
March 31, 2026 5:16 PM - SEC Filing
Advancements in Novel Immunotherapeutics in The Oncology Battle
March 24, 2026 10:32 AM - StreetInsider
TuHURA names former J&J oncology executive as chief medical officer
March 23, 2026 7:45 AM - StreetInsider
Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers
March 23, 2026 7:45 AM - PR NewsWire
Full Article List
